IGF-1 receptor interacting proteins

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007100, C530S350000

Reexamination Certificate

active

10867039

ABSTRACT:
The invention comprises a method of screening compound(s) that inhibit the interaction between IGF-1R and IIP-10.

REFERENCES:
patent: 2915082 (1959-12-01), Shaw
patent: 5650415 (1997-07-01), Tang et al.
patent: 063 879 (1982-11-01), None
patent: 128 018 (1984-12-01), None
patent: 173 251 (1986-03-01), None
patent: 200 362 (1986-12-01), None
patent: 0679716 (1995-11-01), None
patent: WO 89/06698 (1989-07-01), None
patent: WO 95/14772 (1995-06-01), None
patent: WO 97/27296 (1997-07-01), None
patent: WO 0055180 (2000-09-01), None
patent: WO 00 60080 (2000-12-01), None
patent: WO 0073801 (2000-12-01), None
Denley et al., 2005, Mol. Endocrinol., 19(3):711-721.
Zhang et al., 1994, J. Biol. Chem., vol. 269(14), pp. 11609-10613.
Rousset et al.,Oncogene, vol. 16, pp. 643-654 (1998).
De Vries et al.,Proc. Natl. Acad. Sci. USA, vol. 95, pp. 12340-12345 (1998).
No. XP-002102461, Database EMBL ID AF 032120, Bunn et al., “Cloning and Characterization of GLUT1CBP, a Novel PDZ domain-containing Protein that binds Specifically to the GLUT1 Tansporter C-terminus” (1998).
No. XP-002102452, Abstract of Bunn et al., “Identification and Characterization of a Novel Glucose Transporter Binding Protein” (1997).
No. XP-002102462, Database EMBL ID AF061262 (1998).
Lamothe et al.,Gene, vol. 182, pp. 77-80 (1996).
Dey et al.,Gene, vol. 209, pp. 175-183 (1998).
Baserga,Trends in Biology, vol. 14, pp. 50-152 (1996).
Baserga,Perspective in Cancer Research, vol. 55, pp. 249-252 (1995).
Atschul et al.,J. Mol. Biol., vol. 215, pp. 403-410 (1990).
Atschul et al.,Nucleic Acids Res., vol. 25, pp. 3389-3402 (1997).
Bates et al.,Br. J. Cancer, vol. 72, pp. 1189-1193 (1995).
Behrens et al.,Nature, vol. 382, pp. 638-642 (1996).
Behrens et al.,Science, vol. 280, pp. 596-599 (1998).
Burfeind et al.,Proc. Natl. Acad. Sc. USA, vol. 93, pp. 7263-7268 (1996).
Büttnet et al.,Mol. Cell. Biol., vol. 11, pp. 3573-3583 (1997).
Cabral et al.,Nature, vol. 382, pp. 649-652 (1996).
Chomcyzynski et al.,Anal. Biochem., vol. 162, pp. 156-159 (1987).
Chowdhury et al.,Mech. Dev., vol. 39, pp. 129-142 (1992).
Cooke et al.,New Biol., vol. 1, pp. 66-74 (1989).
Denny et al.,Gene, vol. 106, pp. 221-227 (1991).
Dey et al.,Mol. Encocrinol., vol. 10, pp. 631-641 (1996).
Feinberg et al.,Anal. Biochem., vol. 137, pp. 266-267 (1984).
Fields et al.,Nature, vol. 340, pp. 245-246 (1989).
Goulding et al.,EMBO J., vol. 10, pp. 1135-1147 (1991).
Harrington et al.,EMBO J., vol. 13, pp. 3286-3295 (1994).
He, W., et al.,J. Biol. Chem., vol. 271, pp. 1641-11645 (1996).
Kalebic et al.,Cancer Research, vol. 54, pp. 5531-5534 (1994).
Keleko et alk,Mol. Cell. Biol., vol. 10, pp. 464-473 (1990).
Lamothe et al.,FEBS Lett., vol. 373, pp. 51-55 (1995).
Lehmann et al.,Nucleic Acids Res., vol. 18, pp. 1048 (1990).
Margolis et al.,Proc. Natl. Acad. Sc. USA, vol. 89, pp. 8894-8898 (1992).
Morrione et al.,J. Virol., vol. 69, pp. 5300-5303 (1995).
Morrione et al.,Cancer Research, vol. 56, pp. 3165-3167 (1996).
Needleman et al.,J. Biol. Chem., vol. 48, pp. 443-453 (1970).
Pearson,Methods in Enzymology, Academic Press, San Diego, CA, USA, vol. 183, pp. 63-68 (1990).
Ponting et al.,BioEssays, vol. 19, pp. 469-479 (1997).
Prager et al.,Proc. Natl. Acad. Sci. USA, vol. 91, pp. 2181-2185 (1994).
Quinn et al.,J. Biol. Chem., vol. 271, pp. 11477-11483 (1996).
Resnicoff et al.,Cancer Research, vol. 54, pp. 2218-2222 (1994).
Resnicoff et al.,Cancer Research, vol. 54, pp. 4848-4850 (1994).
Resnicoff et al.,Cancer Research, vol. 55, pp. 2463-2469 (1995).
Resnicoff et al.,Cancer Research, vol. 55, pp. 3739-3741 (1995).
Reidel et al., J.Biochem, vol. 122, pp. 1105-1113 (1997).
Rocchi et al.,Endocrinology, vol. 137, pp. 4944-4952 (1996).
Rogler et al.,J. Biol. Chem., vol. 269, pp. 13779-13784 (1994).
Sell et al.,Cancer Research, vol. 55, pp. 303-305 (1995).
Sell et al.,Mol. Cell. Biol., vol. 14, pp. 3604-3612 (1994).
Sell et al.,Proc. Natl. Acad. Sci. USA, vol. 90, pp. 11217-11221 (1993).
Singleton et al.,Cancer Research, vol. 56, pp. 4522-4529 (1996).
Smith et al.,Adv. Appl. Math., vol. 2, pp. 482-489 (1981).
Tartare-Deckert et al.,Endocrinology, vol. 137, pp. 1019-1024 (1996).
Tartare-Deckert et al., J.Biol. Chem., vol. 270, pp. 23456-23460 (1995).
Trojan et al.,Science, vol. 259, pp. 94-97 (1993).
Ullrich et al.,EMBO J. , vol. 5, pp. 2503-2512 (1986).
Wahl et al.,Proc. Natl. Acad. Sci. USA, vol. 76, pp. 3683-3687 (1979).
Wang et al.,J. Biol. Chem., vol. 273, pp. 3136-3139 (1998).
Weidner et al.,Nature, vol. 384, pp. 173-176 (1996).
Yokouchi et al.,Oncogene, vol. 15, pp. 7-15 (1998).
Abstract of WO 95/14772 (Document B2).
Abstract of WO 89/06698 (Document B3).
Lin et al.,J. Exp. Clin. Cancer Res., vol. 15 (1996) 319-326.
Van Der Laan et al,Thyroid, vol. 5, (1995) 67-73.
Stratagene 1993 Product Catalog, p. 43.
NCI-CGAP, GenBAnk Accession No. AA515857, Nov. 13, 1997.
Wang and Strittmatter, GenBank Accession No. AF061623, Nov. 10, 1998.
DeVries et al., GenBank Accession No. AF089816, Oct. 24, 1998.
XP002178662 Database EMBL ID: HS1309495, AC AA515857, (Jul. 15, 1997) “NI30D01.SL nci—cgap—Ew1Homo sapienscDNA clone IMAGE:971809 similar to TR:G9957778 G995778 CTHY28KD. mRNA sequence”.
XP002178663 Database EMBL ID: HS1314130, AC AA522515, (Jul. 18, 1997) “ni38c02.s1 NCI—CGAP—Lu1Homo sapienscDNA clone IMAGE:979106 3′ similar to TR:G995778 G995778 CTHY28KD. mRNA sequence”.
XP002178664 Database EMBL ID: HS451342, AC W40451, (May 21, 1996) Hillier L. et al.
XP002178665 Database EMBL ID: HS798260, AC N23798 (Dec. 29, 1995) Hillier L. et al.
XP002178666 Database EMBL ID: GG34350, AC U34350, (Sep. 24, 1995) Compton M.M. and Thompson J.M.
XP002178667 Database EMBL ID: Q90679, AC Q90679, (Nov. 1, 1996) Compton M.M. and Thompson J.M.
Dey et al., GENE vol. 209 No. 1-2 (Mar. 16, 1998) pp. 175-183.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

IGF-1 receptor interacting proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with IGF-1 receptor interacting proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IGF-1 receptor interacting proteins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3763679

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.